BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kornberg A, Witt U, Kornberg J, Müller K, Friess H, Thrum K. Prophylactic Anti-Cytomegalovirus Hyperimmunoglobulin in Critically Ill Liver Transplant Patients: Impact on Early Immunology and Survival. J Clin Med 2020;9:E656. [PMID: 32121313 DOI: 10.3390/jcm9030656] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Liu H, Zhou L, Wang D, Wang S, Liu Q, Wu Y, Tu M, Sun Z, Zheng X, Fu B, Wang B, Wei H. Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation. iScience 2022;25:105065. [PMID: 36147955 DOI: 10.1016/j.isci.2022.105065] [Reference Citation Analysis]
2 Barten MJ, Baldanti F, Staus A, Hüber CM, Glynou K, Zuckermann A. Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis. Life 2022;12:361. [DOI: 10.3390/life12030361] [Reference Citation Analysis]
3 Deml L, Hüber CM, Barabas S, Spindler T, Cozzi E, Grossi P. Stimulatory Effect of CMV Immunoglobulin on Innate Immunity and on the Immunogenicity of CMV Antigens. Transplant Direct 2021;7:e781. [PMID: 34712781 DOI: 10.1097/TXD.0000000000001236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]